Advanced Search

Headache Self-Management factsheet - 2013, revised 2016 Link to Alberta Ambassador Guideline Adaptation Program

Headache Pain factsheet - 2013, revised 2016 Link to Alberta Ambassador Guideline Adaptation Program

Medication Overuse Headache factsheet - 2013, revised 2016 Link to Alberta Ambassador Guideline Adaptation Program

Migraine Headache factsheet - 2013, revised 2016 Link to Alberta Ambassador Guideline Adaptation Program

Migraine Preventive Medications factsheet - 2013, revised 2016 Link to Alberta Ambassador Guideline Adaptation Program

Tension-type Headache factsheet - 2013, revised 2016 Link to Alberta Ambassador Guideline Adaptation Program

This lists all the documents/websites relevant to the guideline that are available on the IHE and TOP websites, both clinician and patient resources. Link to Alberta Ambassador Guideline Adaptation Program

Headache During Pregnancy and Breastfeeding factsheet - 2016 Link to Alberta Ambassador Guideline Adaptation Program

What You Should Know About Your Headache - Patient Brochure - 2016 Link to Alberta Ambassador Guideline Adaptation Program

Objective: Public health decision makers not only consider health benefits but also economic implications when articulating and issuing lifestyle recommendations. Whereas various estimates exist for the economic burden of physical inactivity, excess body weight and smoking, estimates of the economic burden associated with our diet are rare. In the present study, we estimated the…

This initiative is being led by the NOAHE Working Group, a partnership between health economists and policy leaders from the Institute of Health Economics (IHE), the Universities of Alberta and Calgary, and Alberta Health. Objectives of NOAHE: To improve health economics capacity in Alberta. To facilitate collaboration between the health economics researchers. To bring together…

12 December 2016 Ottawa, Ontario On December 12th, 2016, the Institute of Health Economics (IHE) held a roundtable discussion regarding the role of real-world evidence (RWE) in decision-making in Canada, with a focus on RWE generated for pricing and reimbursement. Download Summary Report Real-world evidence: What role can it play in real-world decision making? Summary Report The…

On December 12th, 2016, the Institute of Health Economics (IHE) held a roundtable discussion regarding the role of real-world evidence (RWE) in decision-making in Canada, with a focus on RWE generated for pricing and reimbursement. The meeting brought together 11 representatives of key stakeholders: experts in evidence assessment, payers, and those generating RWE including academia…

This overview report provides a summary of the published information on the oxygen therapy issues studied in the past 10 years in the acute care settings. The report includes a summary of audit studies that aimed to address appropriate/inappropriate use of oxygen, and explores the safety and quality issues identified in the literature about oxygen prescription, administration,…

This report provides a summary of the IHE Biosimilars Forum engagement exercise that took place on October 6, 2016 in Edmonton. The intent of the forum was to inform Alberta biosimilar reimbursement policy by sharing international experiences in this area, and the perspectives of key stakeholders.

This rapid report provides a summary of current evidence on the application of gainsharing shared savings strategies in healthcare systems and the barriers and facilitators related to their implementation.

Economic evaluation helps policy makers and healthcare payers make decisions on drug listing, coverage, and reimbursement. When economic evaluations are conducted before a product launch, the prices of the pharmaceuticals have to be forecast.

7 November 2016Edmonton, Alberta Welcome and Greetings Master of CeremoniesDr. Lorne Tyrrell, Chair, Institute of Health Economics Greetings from GovernmentMr. Martin Chamberlain, Senior Assistant Deputy Minister, Ministry Operations and Financial and Corporate Services, Alberta Health https://vimeo.com/channels/907291/191869994 Keynote presentations Assessing European Efforts…

7 November 2016Edmonton, Alberta Controlling Health Care Costs – Wisely is the 16th IHE Innovation Forum, a semi-annual event bringing together senior public- and private-sector experts and decision-makers to address health care policy issues. Our 16th IHE Innovation Forum Keynote Speakers were Dr. Richard B. Saltman, Co-founder of the European Observatory on Health Systems…

Speaker Biographies Keynote Speakers Dr. Gregory P. Marchildon, PhD Ontario Research Chair in Health Policy and System Design and Professor, Institute of Health, Policy and Evaluation, University of Toronto Associate Editor of the Health Reform Observer and originating member of the Pan-Canadian Health Reform Analysis Network (PHRAN) Dr. Marchildon is Ontario Research Chair in…

Controlling Health Care Costs – Wisely is the 16th IHE Innovation Forum, a semi-annual event bringing together senior public- and private-sector experts and decision-makers to address health care policy issues.

PDF of a PowerPoint presentation by Dr. Gregory P. Marchildon, Ontario Research Chair in Health Policy and System Design and Professor, Institute of Health, Policy and Evaluation, University of Toronto; Associate Editor of the Health Reform Observer and originating member of the Pan-Canadian Health Reform Analysis Network (PHRAN). IHE Innovation Forum XVI – Controlling Health…

The IHE Lay Advisory Committee is a unique group of citizens committed to providing public perspective on a wide range of medical and/or health services topics. The IHE Lay Advisory Committee welcomes the opportunity to leverage existing resources and collaborate with other organizations within Alberta who have a public participation mandate. If your organization requires public…

The Institute of Health Economics (IHE), in partnership with the Canadian Pulmonary Fibrosis Foundation (CPFF), held a forum on April 25th, 2016 in Toronto, Ontario, entitled Optimizing access to care for patients with idiopathic pulmonary fibrosis: A multi-stakeholder national forum, to discuss the need for patient-led policy recommendations and a patient charter for idiopathic…

IHE Innovation and Industry Engagement The IHE has a pan-Canadian program area dedicated to issues and topics of strategic importance to the private sector life sciences industry. The program area employs a unique and robust stakeholder engagement model to enable collaboration between government, industry, and academia, to help promote the co-development of solutions to complex…

  BACKGROUND: In February 2013, Alberta Health Services established an Enhanced Recovery After Surgery (ERAS) implementation program for adopting the ERAS Society colorectal guidelines into 6 sites (initial phase) that perform more than 75% of all colorectal surgeries in the province. We conducted an economic evaluation of this initiative to not only determine its cost-effectiveness,…

Thursday, 6 October 2016 Edmonton, Alberta 09:00 – 09:15 Introduction & WelcomeDr. Richard Fedorak 09:15 –10:15 The International Biosimilars Experience: Lessons for AlbertaMr. Murray AitkenSenior VP and Executive Director, IMS Institute for Healthcare InformaticsDownload Presentationhttps://vimeo.com/album/4209638/video/187499107 10:15 – 10:45 Table Reflection…

Biographies Dr. Richard N Fedorak, MD, FRCPC, FRCP (London), FRSC Dean of the Faculty of Medicine and Dentistry Professor of Medicine, Division of Gastroenterology University of Alberta, Edmonton, Alberta, Canada Dr. Richard N Fedorak is Dean of the Faculty of Medicine and Dentistry at the University of Alberta, Edmonton, Alberta, Canada. He is also Professor of Medicine in the…

6 October 2016 Edmonton, Alberta This IHE Invitational Forum provided the perspective of international, national, and Alberta speakers and panellists to describe the biosimilar reimbursement approach taken and outcomes achieved by other jurisdictions, guiding principles and policy options for Alberta, and key performance indicators and targets for reimbursement policy going forward.…

Summary Report Towards an Alberta approach for biosimilar reimbursement – Summary report of the IHE Biosimilars ForumDownload Summary Report Program IHE Biosimilars Forum – Final ProgramDownload Final Program

This IHE Invitational Forum provided the perspective of international, national, and Alberta speakers and panellists who described the biosimilar reimbursement approach taken and outcomes achieved by other jurisdictions, guiding principles and policy options for Alberta, and key performance indicators and targets for reimbursement policy going forward.

PDF of a PowerPoint presentation by Dr. Asbjørn Mack, Chief Negotiator Pharamaceuticals, LIS, Norway. 6 Oct 2016 – IHE Biosimilars Forum

PDF of a PowerPoint presentation by Mr. Murray Aitken, Senior VP and Executive Director, IMS Institute for Healthcare Informatics. 6 Oct 2016 – IHE Biosimilars Forum

The white paper concludes that the knowledge and technology needed to fill many of the gaps in care identified already exists in Canada. There is an important role that non-profit and networking organizations such as the national and provincial Lung Associations, the Canadian Thoracic Society, the Canadian Foundation for Health Improvement, and the Strategic Clinical Networks can…

This lists all the documents/websites relevant to the guideline that are available on the IHE and TOP websites, both clinician and patient resources. Link to Alberta Ambassador Guideline Adaptation Program

This white paper follows on from the 2016 IHE report, Economic surveillance for chronic obstructive pulmonary disease (COPD) in Alberta. It provides a summary of main gaps in COPD care across Canada and, in the context of a broad economic framework, it surveys important examples of programs and policies designed to address these gaps.

  OBJECTIVES: This study aimed to evaluate the trends and regional variation of stroke hospital care in 30-day in-hospital mortality, hospital length of stay (LOS), and 1-year total hospitalization cost after implementation of the Alberta Provincial Stroke Strategy.

“The Canadian Idiopathic Pulmonary Fibrosis Patient Charter is a way to call upon policymakers, health care providers and private payers to recognize IPF as a rare, rapidly lethal, chronic disease and to join in the campaign for greater awareness of this illness. The ultimate goal is to improve the overall quality and standards of care and ensure equal access to a continuum…

Speaker Biographies Keynote Speakers Dr. Clemens Hong, MD, MPHMedical Director, Community Health Improvement, Community Health & Integrated Programs, County of Los Angeles Department of Health Services Dr. Hong is a primary care physician and the Medical Director of Community Health Improvement at the Los Angeles County Department of Health Services. His work centers on approaches…

22 June 2016Edmonton, Alberta High Needs & High Cost Patients in Healthcare – How do we improve outcomes for these patients? is the 15th IHE Innovation Forum, a semi-annual event bringing together senior public- and private-sector experts and decision-makers to address health care policy issues. Our 15th IHE Innovation Forum Keynote Speakers were Dr. Clemens Hong, Medical…

22 June 2016Edmonton, Alberta Welcome and Greetings Master of CeremoniesDr. Lorne Tyrrell, Chair, Institute of Health Economics Welcome RemarksMs. Heather Sweet, Member of Legislative Assembly, Edmonton-Manning; Dr. Alan Casson, Interim Assistant Deputy Minister of Health Standards, Quality and Performance and Senior Provincial Medical Advisor, Ministry of Health, Government of…

High Needs & High Cost Patients in Healthcare – How do we improve outcomes for these patients? is the 15th IHE Innovation Forum, a semi-annual event bringing together senior public- and private-sector experts and decision-makers to address health care policy issues.

PDF of a PowerPoint presentation by Mr. Truman Severson, Vice President, Innovation and Business Development, Covenant Health. IHE Innovation Forum XV – High Needs & High Cost Patients in Healthcare – How do we improve outcomes for these patients?

PDF of a PowerPoint presentation by Dr. Clemens Hong, MD, MPH, Medical Director, Community Health Improvement, Community Health & Integrated Programs, County of Los Angeles Department of Health Services. IHE Innovation Forum XV – High Needs & High Cost Patients in Healthcare – How do we improve outcomes for these patients?

PDF of a PowerPoint presentation by Dr. Richard Lewanczuk, Senior Medical Director, Provincial Primary Health Care, Alberta Health Services; Professor, Department of Medicine, University of Alberta. IHE Innovation Forum XV – High Needs & High Cost Patients in Healthcare – How do we improve outcomes for these patients?

  BACKGROUND: Eplerenone has been demonstrated as being cost effective for the treatment of patients with systolic heart failure (HF) and mild symptoms in several jurisdictions; however, its cost effectiveness is unknown in the context of Alberta, Canada.

  Objective: The objective of this paper is to estimate the additional mental health service costs incurred within the criminal justice system that are incurred because of people with mental illnesses who go through the system. Our focus is on costs in Alberta.

The Institute of Health Economics (IHE) together with the O’Brien Institute for Public Health (O’Brien Institute) held a policy forum on February 8th, 2016, entitled Physicians as Stewards of Resources: Roles, Responsibilities, and Remuneration to inform decision-making regarding the fiscal sustainability of theprovincial healthcare system, with a specific…

This PDF is a summary infographic related to the Economic surveillance for chronic obstructive pulmonary disease (COPD) in Alberta report.

Objectives: In 2006, the Alberta Ministry of Health issued a policy to implement fetal fibronectin (fFN) testing as a publicly funded service for pregnant women. The goals were to reduce maternity health care utilization and unnecessary treatment, which would result in cost-savings for the health system by more accurately diagnosing false preterm labour. We conducted a post-policy…

This guide has been developed by the information specialists at the Institute of Health Economics in Edmonton Alberta and is intended to facilitate searching for health technology assessments (HTAs) or systematic reviews by providing the list of current and reliable internet-based resources that we regularly use in our work. We have tried as much as possible to match this guide…

Policy leaders and COPD specialists recently gathered in Halifax, Nova Scotia, in conjunction with the 2016 Canadian Respiratory Conference, to discuss the findings of the Institute of Health Economics’ newly released report, The Economic Surveillance for Chronic Obstructive Pulmonary Disease (COPD) in Alberta. The report addressed a gap in health economic information that…

Summary Report Optimizing access to care for patients with idiopathic pulmonary fibrosis multi-stakeholder national forum – Summary report and recommendations for policy-makingDownload Summary Report Program Optimizing Access to Care for Patients with Idiopathic Pulmonary Fibrosis Multi-stakeholder National Forum – AgendaDownload Agenda Background Document Optimizing…

Monday, 25 April 2016 Toronto, Ontario Moderator: Chris Henshall Opening and Opening Remarks Don Husereau, IHEMehmood Alibhai, Boehringer Ingelheim (Canada) Ltd./LtéeDr. Chris Henshall, Chair, Health Technology Assessment International Policy Forumhttps://vimeo.com/album/3989243/video/169906196 Health care policy and idiopathic pulmonary fibrosis: Values of patients…

25 April 2016 Toronto, Ontario On April 25th, The Institute of Health Economics (IHE), in partnership with the Canadian Pulmonary Fibrosis Foundation (CPFF) and supported by an unrestricted grant from Boehringer Ingelheim (Canada) Ltd. (BI), held a national, multi-stakeholder roundtable forum to discuss policy recommendations on idiopathic pulmonary fibrosis (IPF) care. The forum…

Today, a group of 30-40 societal representatives, including policy-makers and health system administrators, experts in technology assessment, as well as patients, formal and informal care providers, gathered in Toronto, Ontario, to discuss draft evidence-informed policy recommendations on idiopathic pulmonary fibrosis (IPF). IPF is a terminal, chronic respiratory disease, characterized…

PDF of a PowerPoint presentation by Dr. Martin Kolb, MD, PhD, Professor, Division of Respirology, Department of Medicine, McMaster University. Optimizing Access to Care for Patients with Idiopathic Pulmonary Fibrosis: A Multi-stakeholder National Forum

PDF of a PowerPoint presentation by Dr. Meena Kalluri, MD, Assistant Professor, Division of Pulmonary Medicine, University of Alberta. Optimizing Access to Care for Patients with Idiopathic Pulmonary Fibrosis: A Multi-stakeholder National Forum

PDF of a PowerPoint presentation by Mr. Robert Davidson, President, Canadian Pulmonary Fibrosis Foundation (CPFF). Optimizing Access to Care for Patients with Idiopathic Pulmonary Fibrosis: A Multi-stakeholder National Forum

In October 2015, we held the first Canadian consensus discussion that led to provisional recommendations regarding special considerations for policy-making and healthcare decisionmaking for interventions in patients with idiopathic pulmonary fibrosis (IPF). The meeting included 11 representatives of key stakeholders: patients, care providers, and policy researchers from across…

On April 25th, The Institute of Health Economics (IHE), in partnership with the Canadian Foundation for Pulmonary Fibrosis (CPFF) and supported by an unrestricted grant from Boehringer Ingelheim (Canada) Ltd. (BI), held a national, multi-stakeholder roundtable forum to discuss policy recommendations on idiopathic pulmonary fibrosis (IPF) care.

This report provides the results of an economic surveillance analysis on the components of the Alberta healthcare system that are devoted to COPD prevention and treatment. It focuses on epidemiology (prevalence and incidence), service use, and cost indicators, and identifies gaps in the system that presumably add to the overall economic burden of COPD. PDF of the above image:  IHE…

IHE brochure discussing a study on the use of technology to prevent FASD (fetal alcohol spectrum disorder). FASD Ongoing Initiative Prevention of Fetal Alcohol Spectrum Disorder by the Use of Technology Study

Alberta STE Report written under contract with the Alberta Health Technologies Decision Process (AHTDP). This STE report examines the safety, screening accuracy, therapeutic efficacy/effectiveness, cost-effectiveness, budget impact, and health system readiness of newborn screening for seven conditions (galactosemia, tyrosinemia type I, homocystinuria, sickle cell anemia, sickle…

  Objectives: To estimate the life expectancy and specify the causes of death among people with fetal alcohol syndrome (FAS). Methods: Included were all patients recorded in Alberta provincial databases of inpatients, outpatients, or practitioner claims from 2003 to 2012. People with FAS were identified by ICD-9 code 760.71 and ICD-10 codes Q86.0 and P04.3, and were linked…

The Alberta Ambassador Program, hosted by the Health Technology Assessment Unit of the IHE, is a knowledge translation strategy. The guideline was created for the Alberta context by a group of multidisciplinary clinicians and researchers in Alberta, based on the best available low back pain guidelines from Canada and around the world. Over the three editions of the guideline, the…

The IHE quality appraisal checklist for case series studies developed by a group of researchers at the Institute of Health Economics (IHE) in collaboration with researchers from two other health technology assessment (HTA) agencies in Australia and Spain.

The IHE Quality Appraisal Checklist for Case Series Studies and guidance document developed by a group of researchers at the Institute of Health Economics (IHE) in collaboration with researchers from two other health technology assessment (HTA) agencies in Australia and Spain.

Alberta STE Report written under contract with the Alberta Health Technologies Decision Process (AHTDP). This rapid report has been produced in response to a request from Alberta Health to provide an update on the new published research evidence on the efficacy/effectiveness, efficiency, and safety of hysteroscopic tubal sterilization (HTS) using the Essure® system for permanent…

The Institute of Health Economics (IHE) is a unique collaborative arrangement among government, academia, and industry. Established in 1995, the IHE is committed to gathering and disseminating evidence-based findings from health economics, health policy, health technology assessment and comparative effectiveness research to support health policy and practice.  

The economics of addictions and mental health deals with how we can best distribute available resources and achieve good mental health outcomes. A variety of techniques, such as health technology assessments, costing, cost effectiveness, and cost benefit analysis are used to provide information for policy makers. IHE has been active in the area of economic evaluations of mental…

Alberta STE Report written under contract with the Alberta Health Technologies Decision Process (AHTDP). This report is an update of the “Technological efficacy/effectiveness analysis” (T) section of the 2014 Alberta STE report, which was an evidence assessment of the clinical effectiveness and safety of endovenous ablation interventions for symptomatic varicose veins…

Fetal alcohol spectrum disorder (FASD) refers to several disorders caused by the use of alcohol during pregnancy. People born with FASD will experience serious physical and mental problems. In Alberta 46,000 people currently live with FASD and approximately 700-1900 babies are born with FASD in the province each year. The goal of this study is to see how a Mobile Alcohol Measuring…

Career Opportunities at the Institute of Health Economics Thank you for your interest in the Institute of Health Economics. There are no opportunities available at this time.

“Alberta’s system for paying doctors is overly expensive, outdated and prevents the health system from making necessary reforms, Health Minister Sarah Hoffman said Monday. Speaking to a group of health leaders in Edmonton, Hoffman said urgent changes to physician pay models are needed to both improve the quality of care offered patients and to help the government deal…

  Abstract: Canada having a universal health insurance plan that provides hospital and physician benefits offers a natural experiment of whether continuity ofcare actually provides lower or higher utilization of services. The question we are evaluating is whether Canadians, who have a regular physician, use more health resources than those who do not have one? Using two statistical…

The Institute of Health Economics (IHE) together with the O’Brien Institute for Public Health (O’Brien Institute) held a policy forum on February 8th, 2016, entitled Physicians as Stewards of Resources: Roles, Responsibilities, and Remuneration to inform decision-making regarding the fiscal sustainability of the provincial healthcare system, with a specific focus…

The checklist has been used by researchers at IHE in HTA reports as well as by professionals in other organizations from various countries. Listed in reverse chronological order and updated on March 3rd, 2016. IHE Publications Institute of Health Economics. Hysteroscopic Tubal Sterilization. Edmonton AB: Institute of Health Economics. 2014. Download IHE Report Institute of Health…

The process by which the tool was developed, as well as a brief review of other published checklists and the results of a pilot test of the quality appraisal checklist are described in a 2012 IHE methodology paper. A preliminary validation study of the tool using factor analysis has also been conducted. Publications Listed in reverse chronological order. Guo B, Moga C, Harstall…

Policy Forum Summary Report Physicians as Stewards of Resources: Roles, Responsibilities and Remuneration Policy Forum – Summary Report Download Summary Report Program Policy Forum – Final ProgramDownload Final Program Background Document Alberta Fact SheetDownload Alberta Fact Sheet Forum Summary Policy Forum InfographicDownload Infographic

Monday, 8 February 2016 Edmonton, Alberta Please click the following link to watch video of afternoon sessions: Event Video 09:00 – 09:10 Welcome and Opening RemarksIHE and O'Brien Institute Leadershiphttps://vimeo.com/album/3800131/video/155338361 Morning Session: Understanding Our Shared Challenges 09:10 – 09:25 Setting the Stage: An Overview of Health Spending, Physician…

Biographies Dr. William Ghali, MD, MPH, FRCPCScientific Director, O'Brien Institute for Public Health Dr. Ghali is the Scientific Director of the O’Brien Institute for Public Health at the University of Calgary. He is also a Professor in the Departments of Medicine and Community Health Sciences at the University of Calgary, and a practicing physician specialized in Internal…

8 February 2016 Edmonton, Alberta The IHE/O’Brien Physicians as Stewards of Resources: Roles, Responsibilities, and Remuneration Policy Forum aimed to inform decision-making regarding the fiscal sustainability of the provincial healthcare system, with a specific focus on physicians as stewards of public resources. The forum, which was attended by Health Minister Sarah Hoffman…

The IHE/O’Brien Physicians as Stewards of Resources: Roles, Responsibilities and Remuneration Policy Forum aims to inform decision-making regarding the fiscal sustainability of the provincial healthcare system, with a specific focus on physicians as stewards of public resources. The forum, which will also be attended by Health Minister Sarah Hoffman as lunch keynote speaker,…

PDF of a PowerPoint presentation by Dr. William Ghali, MD, MPH, FRCPC, Scientific Director, O'Brien Institute for Public Health. IHE/O’Brien Physicians as Stewards of Resources: Roles, Responsibilities, and Remuneration Policy Forum

PDF of a PowerPoint presentation by Dr. David Naylor, President Emeritus and Professor of Medicine, University of Toronto. IHE/O’Brien Physicians as Stewards of Resources: Roles, Responsibilities, and Remuneration Policy Forum

PDF of a PowerPoint presentation by Dr. Peter Kaboli, Hospitalist and Chief of Medicine, Iowa City VA Healthcare System. IHE/O’Brien Physicians as Stewards of Resources: Roles, Responsibilities, and Remuneration Policy Forum

PDF of a PowerPoint presentation by Dr. David Price, Professor and Chair, Department of Family Medicine, McMaster University. IHE/O’Brien Physicians as Stewards of Resources: Roles, Responsibilities, and Remuneration Policy Forum

PDF of a PowerPoint presentation by Dr. Sharon Straus, Professor, Department of Medicine, University of Toronto. IHE/O’Brien Physicians as Stewards of Resources: Roles, Responsibilities, and Remuneration Policy Forum

PDF of a PowerPoint presentation by Dr. Carl Nohr, President, Alberta Medical Association, and Mr. Mike Gormley, Executive Director, Alberta Medical Association. IHE/O’Brien Physicians as Stewards of Resources: Roles, Responsibilities, and Remuneration Policy Forum

As a result, leading healthcare minds from Alberta, Canada and the U.S. will descend on Edmonton on February 8 as part of a policy forum being hosted by the O’Brien Institute for Public Health, from the Cumming School of Medicine, and in partnership with the Institute of Health Economics, aiming to inform decision-making at Alberta Health regarding the fiscal sustainability…

2016 | 2015 | 2014 | 2013 The Institute of Health Economics joined with Alberta Innovates (formerly known as Alberta Innovates-Health Solutions) in 2013 to create a new forum to bring stakeholders together to discuss health policy. The AI/IHE Health Policy Speaker Series features perspectives from leaders in the health system across the spectrum of health evidence, policy, and…

Acute Low Back Pain Brochure - 2016 Link to Alberta Ambassador Guideline Adaptation Program

Chronic Low Back Pain Brochure - 2016 Link to Alberta Ambassador Guideline Adaptation Program

Low Back Pain companion document - 2016 Link to Alberta Ambassador Guideline Adaptation Program

1st International Conference on FASD Prevention 23 – 25 September 2013 IHE hosted the First International Conference on Prevention of FASD, September 23 - 25, 2013 in Edmonton, Alberta. More than 800 people were in attendance, including global experts and leaders in the health system, government, and the academic and business communities. Event Link | The International…

Primary Care Low Back Exam factsheet - 2006.  Extracted from the Chronic Pain Management Binder November 2005.  Link to Alberta Ambassador Guideline Adaptation Program

Overview Conducting the Event The conferences usually involve 15 or more experts who deliver the scientific evidence and testimony around 5-8 specific questions on a particular health subject. They deliver this evidence to a jury of 12-15 people over two days in front of an audience of 300+ people. The consensus format provides an independent look at issues from an unbiased panel.…

Fetal Alcohol Spectrum Disorder (FASD) is caused by alcohol use during pregnancy. No amount of alcohol is known to be safe for an unborn child at any stage in its development. Alcohol consumed by the mother during pregnancy easily crosses the placenta and can cause a range of developmental defects that result in both physical diseases and intellectual disabilities. In particular,…

Ongoing research and evaluation of programs will help to determine best practices for preventing FASD and supporting those already affected. The Government of Alberta's Fetal Alcohol Spectrum Disorder Cross-ministry Committee has a comprehensive website with extensive resources on FASD. Visit their site at http://fasd.alberta.ca/ or select from the links below for FASD research…

This consensus development conference was commissioned by the Government of Alberta to improve the transition of its system of care for people with severe and persistent mental illness (SPMI) toward the community. The system, previously hospital- and institution-centred, is moving towards becoming a community-centred, patient- and family-led one. The development and deployment…

À titre de président du jury, le Dr Alain Lesage, M.D., FRCPC, M.Phil., DFAPA, professeur au département de psychiatrie de l'Université de Montréal et clinicien à l’Institut universitaire en santé mentale de Montréal, Québec, a dirigé un comité spécial dont le mandat était d'élaborer…

The IHE began doing research and engaged in knowledge transfer activities in the field of FASD in 2008. Since then the Institute has hosted several events and researchers at the Institute have developed more than 25 publications, of which 10 are published in peer reviewed journals.

Clinical Resources | Patient Resources  Clinical Practice Guideline Primary Care Management of Headache in Adults (2nd edition September 2016) Guideline Documents including Full Guideline hosted by Towards Optimized Practice (TOP) Albertahttp://www.topalbertadoctors.org/cpgs/10065 Supporting Documents and Process Description Background Document, 2nd Edition.2nd Edition Coming…

Clinical Resources | Patient Resources  Clinical Practice Guideline Evidence-Informed Primary Care Management of Low Back Pain(3rd edition, December 2015) Guideline Documents including Full Guideline hosted by Towards Optimized Practice (TOP) Albertahttp://www.topalbertadoctors.org/cpgs/885801  Supporting Documents and Process Description Background Document, 3rd Edition.…

  INTRODUCTION: The objective of this study was to determine the short-term cost impact thatmedical tourism for bariatric surgery has on a public healthcare system. Due to long wait times for bariatric surgery services, Canadians are venturing to private clinics in other provinces/countries. Postoperative care in this population not only burdens the provincial health system…

Changing how Alberta pays for health care is critical to improve value, achieve better quality, and slow cost growth. There is need in Alberta for capacity in applied economics knowledge to enhance economic surveillance that is independent from government, but supports ongoing provincial development of the organizational and incentive structures for funding the health service delivery…

As our name implies, health economics is a core component of what we do. The Institute provides economic analysis at both the system level (in broad areas of health-sector management and significant disease burdens such as cancer and mental health) as well as economic evaluation of individual technologies and therapeutic interventions. We study health economics and…

How do you engage citizens, decision-makers, and experts in an appropriate way to address complex health issues? One approach is the Consensus Development Conference. The Consensus Development Conference approach has been used effectively in Alberta by the Institute of Health Economics. The program is modelled on the National Institute of Health (NIH) Consensus Development…

In December 2008, the IHE launched a series of semi-annual innovation forums whose goal is to bring together senior public- and private-sector decision-makers to address policy issues of importance in the healthcare system, not just in Alberta, but to all of Canada and the international community, as well. Details of each session are available by selecting the appropriate link.…

IHE serves as a neutral convenor for health policy dialogue and evidence development and dissemination. The format for each event is tailored to suit the topic, purpose, and audience. Included in this portfolio is the IHE's well-regarded Consensus Development Conference Series, which has seen us host international events on Fetal Alcohol Spectrum Disorder and Depression in…

Promoting the use of evidence to encourage and support best practice in pain management The Alberta Ambassador Guideline Adaptation Program started in 2004 as a knowledge translation (KT) strategy for promoting the use of research evidence to encourage and support best practice in primary care across the province. The Program is an active collaboration of individuals and agencies…

Informed Decision-Making for Health Established by the Alberta Ministry of Health in 1994, the HTA Program has been part of the Institute of Health Economics (IHE) since 2006. The Program’s expertise is unique in Canada, with a multidisciplinary staff including experts in general medicine, epidemiology, biomedical engineering, biostatistics, health economics, health services…

Chair Dr. Lorne Tyrrell, Director, Li Ka Shing Institute of Virology, University of Alberta Government and Public Authorities Mr. Justin Riemer, Assistant Deputy Minister, Alberta Health Mr. Jason Krips, Deputy Minister, Economic Development and Trade Mr. Reg Joseph, Vice President, Health, Alberta Innovates Dr. Kathryn Todd, Vice-President Research Innovation & Analytics,…

Academic University of Alberta http://www.ualberta.ca/ The U of A is a leader in research. Our campuses attract professors with international reputations and connections - leaders who are interested in making a difference in the world. At the U of A, the brightest minds in the arts, humanities and sciences gather, putting their expertise to work in the classroom and in the community.…

The outcome of IHE initiatives is providing better information for developing health policy and best medical practices. IHE disseminates information in many ways. In addition to publications in peer-reviewed journals, IHE produces books and a variety of reports synthesizing information in a particular field. 

The IHE is frequently requested to be a partner on academic grant applications and policy initiatives with other organizations. In particular we are often the economic analysis partner or knowledge transfer partner for other organizations. Recent grant proposals, on which we are partners, include: Development, Implementation and Evaluation of the Impact of a Choosing Wisely List…

In November 2014, the Institute of Health Economics partnered with Eli Lilly Canada Inc. and the Canadian Institutes of Health Research’s Institute for Health Services and Policy Research to hold a roundtable to discuss the federal role in healthcare innovation. The roundtable aimed to examine the existing state of healthcare innovation, its strengths and weaknesses (or gaps),…

Speaker Biographies Keynote Speakers Dr. Andreas LaupacisChair, Health Quality Ontario Dr. Laupacis is a general internist and the Executive Director of the Li Ka Shing Knowledge Institute of St. Michael’s Hospital. He is a Professor at the University of Toronto in both the Department of Medicine and the Institute of Health Policy, Management and Evaluation. Dr. Laupacis…

27 November 2014Edmonton, Alberta Welcome and Greetings from the Minister of Health WelcomeDr. Lorne Tyrrell, Chair, Institute of Health Economicshttp://vimeo.com/channels/907291/113749308 Greetings from the ProvinceGlenn Monteith, Chief Delivery Officer, Alberta Healthhttp://vimeo.com/channels/907291/113749310 Keynote presentations Health System Standards: From Good Intent to…

27 November 2014 Edmonton, Alberta Health System Standards: From Good Intent to Real World Application is the 12th IHE Innovation Forum, a semi-annual event bringing together senior public- and private-sector experts and decision-makers to address health care policy issues. Key Forum Documents Innovation Forum XII – Health System Standards: From Good Intent to Real World…

Health System Standards: From Good Intent to Real World Application is the 12th IHE Innovation Forum, a semi-annual event bringing together senior public- and private-sector experts and decision-makers to address health care policy issues.

Click HERE for all information relating to our past events including videos, presentations, conference programs, and more!  

The Institute of Health EconomicsCredits: FASD Research Team - Alberta Innovates; Music - Ben Sound What we do The Institute of Health Economics (IHE) is a not-for-profit organization with key competencies in: Health economics & decision analytic modeling Health technology assessment Knowledge Transfer/Exchange  Core objectives Support decision making in health policy…

IHE Timeline 1994 – The University of Alberta and the Government of Alberta establish a steering committee drawn from the universities of Alberta and Calgary, the Alberta Heritage Foundation for Medical Research, and the federal and provincial governments to explore the feasibility of creating an Alberta-based Institute of Pharmaco-Economics. 1995 – The Institute of…

Stroke Prevention and Management in Primary Care: a free forum at the Accelerating Primary Care Conference 23 November 2014 Edmonton, Alberta This free forum for primary care clinicians was held in conjunction with the annual Accelerating Primary Care conference in Edmonton, Alberta, November 23, 2014. The forum saw three physician leaders review the latest developments in the…

PDF of a PowerPoint Presentation by Dr. Ken Butcher, WMC Health Sciences Centre, University of Alberta. Stroke Prevention and Management in Primary Care: a free forum at the Accelerating Primary Care Conference In this 45 minute presentation, Dr. Butcher reviewed how to diagnose stroke and discussed the burden of Cardioembolic and Cryptogenic Stroke. He talked about the recent…

PDF of a PowerPoint Presentation by Dr. Thomas Jeerakathil, Associate Professor, University of Alberta; Co-physician lead, ASPIRE TIA Triaging Project, Northern Stroke Lead CV/S SCN. Stroke Prevention and Management in Primary Care: a free forum at the Accelerating Primary Care Conference This presentation looked at the diagnosis of likely TIA syndromes and how to identify and…

PDF of a PowerPoint Presentation by Dr. Blair O’Neill, Professor of Medicine, University of Alberta; Interventional Cardiologist, Mazankowski AHI; Senior Medical Director, CV Health and Stroke SCN, Alberta Health Services; Past President, Canadian Cardiovascular Society. Stroke Prevention and Management in Primary Care: a free forum at the Accelerating Primary Care Conference…

This free forum for primary care clinicians was held in conjunction with the annual Accelerating Primary Care conference in Edmonton, Alberta, November 23, 2014. The forum saw three physician leaders review the latest developments in the continuously advancing field of stroke prevention and care, with a particular focus on the role of primary care. The forum was…

PDF of a PowerPoint Presentation by Dr. Blair O’Neill, Professor of Medicine, University of Alberta; Interventional Cardiologist, Mazankowski AHI; Senior Medical Director, CV Health and Stroke SCN, Alberta Health Services; Past President, Canadian Cardiovascular Society. Stroke Prevention and Management in Primary Care: a free forum at the Accelerating Primary Care Conference…

17 November 2014 Ottawa, Ontario The federal Ministry of Health (Health Canada) announced the creation of the Advisory Panel on Healthcare Innovation on June 24, 2014, to examine innovative health care ideas and approaches that exist in Canada and internationally. The Panel’s directive is to determine what approaches hold the greatest potential for Canadians and to create…

Monday, 17 November 2014 Ottawa, Ontario Opening and Opening Remarks Moderator: Mr. John Sproule, IHE Ms. Lauren Fisher, Eli Lilly Canada Inc. Mr. Glenn Brimacombe, Canadian Psyciatric Association Roundtable Discussion: What can the federal government do to promote and support innovation in the healthcare system? Overview of current state of healthcare innovation from a Federal…

Summary Report Health Innovation in Canada: Federal Role Roundtable: Summary ReportDownload Report Background Document Health Innovation in Canada: Federal Role Roundtable – BackgrounderDownload Background Document

The purpose of this roundtable was to gather a small, select group of thought leaders to engage in informed discourse, which was summarized in a report submitted to the new federal Healthcare Innovation Advisory Panel. This roundtable, created in response to the Federal Healthcare Innovation Advisory Panel’s call for stakeholder input, was an exciting opportunity to…

  Objectives: To estimate the annual health services utilization (HSU) cost per person with FASD by sex and age; the lifetime HSU cost per person with FASD by sex, and the annual HSU cost of FASD for Alberta by sex.

  BACKGROUND & AIMS: Infliximab is effective for induction and maintenance of response in patients with moderate to moderately severe ulcerative colitis. Previous cost analyses of infliximab treatment for ulcerative colitis used models of colectomy vs infliximab and response rates derived from early clinical trials. In real life, therapeutic options are more complex; patients…

PDF of a PowerPoint presentation by Dr. Jitender Sareen, MD, FRCPC. Consensus Development Conference on Improving Mental Health Transitions

PDF of a PowerPoint presentation by Mr. David McDaid, BSC, MSc, MSc. Consensus Development Conference on Improving Mental Health Transitions

PDF of a PowerPoint presentation by Dr. Heinz Katschnig, MD. Consensus Development Conference on Improving Mental Health Transitions

PDF of a PowerPoint presentation by Dr. Elliot Goldner, MD, FRC(P), MHSc. Consensus Development Conference on Improving Mental Health Transitions

PDF of a PowerPoint presentation by Dr. Antonio Lora, MD. Consensus Development Conference on Improving Mental Health Transitions

PDF of a PowerPoint presentation by Dr. Luis Salvador-Carulla, MD, PhD. Consensus Development Conference on Improving Mental Health Transitions

PDF of a PowerPoint presentation by Dr. Eric Latimer, PhD. Consensus Development Conference on Improving Mental Health Transitions

PDF of a PowerPoint presentation by Dr. Carol Adair, MSc, PhD. Consensus Development Conference on Improving Mental Health Transitions

PDF of a PowerPoint presentation by Mr. Steve Lurie, BA, MSW, MM. Consensus Development Conference on Improving Mental Health Transitions

PDF of a PowerPoint presentation by Dr. Giovanni de Girolamo, MD, PhD. Consensus Development Conference on Improving Mental Health Transitions

4 – 6 November 2014 Edmonton, Alberta The Institute of Health Economics, in collaboration with the Government of Alberta and with support from Alberta Health Services (AHS), hosted the Consensus Development Conference on Improving Mental Health Transitions in Edmonton, Alberta, from November 4 – 6, 2014. Download Consensus Statement | Télécharger…

 Speakers | Jury | Scientific Committee | Planning Committee   Scientific Chair Roger Bland, CM, MB, ChB, FRCPC, FRCPsych Chair, Scientific Committee; Professor Emeritus, Department of Psychiatry, University of Alberta, Edmonton, Alberta     Speakers Carol Adair, MSc, PhD Researcher, Psychiatric Epidemiologist and Associate Professor,…

Program Consensus Development Conference on Improving Mental Health Transitions 2014 - Final ProgramDownload Program Consensus Statement Consensus Statement on Improving Mental Health Transitions 2014Download Consensus Statement Déclaration de consensus sur l'amélioration des transitions en santé mentaleTélécharger la déclaration de consensus…

Tues 4 Nov 2014 | Wed 5 Nov 2014 | Thu 6 Nov 2014 Improving Mental Health Transitions 2014 - Final Program Tuesday, 4 November 2014 08:00 – 08:45 Opening RemarksRoger Bland, CM, MB, ChB, FRCPC, FRCPsychhttp://vimeo.com/channels/839914/112193615 GreetingsCouncillor Scott McKeenhttp://vimeo.com/112193618 Opening Prayer from ElderGloria Lairdhttp://vimeo.com/112193614…

The Institute of Health Economics, in collaboration with the Government of Alberta and with support from Alberta Health Services (AHS) hosted the Consensus Development Conference on Improving Mental Health Transitions in Edmonton, Alberta, from November 4 - 6, 2014.

PDF of a PowerPoint presentation by Mr. Orrin Lyseng. Consensus Development Conference on Improving Mental Health Transitions

PDF of a PowerPoint presentation by Dr. Linda Gask, MSc, PhD, FRCPsych, FRCGP. Consensus Development Conference on Improving Mental Health Transitions

PDF of a PowerPoint presentation by Dr. Dan Cohen, MD, PhD. Consensus Development Conference on Improving Mental Health Transitions

PDF of a PowerPoint presentation by Dr. Richard Warner, MD, DPM. Consensus Development Conference on Improving Mental Health Transitions

PDF of a PowerPoint presentation by Mr. Gerrit van der Leer. Consensus Development Conference on Improving Mental Health Transitions

PDF of a PowerPoint presentation by Dr. Philippa Garety, MA, MPhil, MA (Ed), PhD, FBPsS. Consensus Development Conference on Improving Mental Health Transitions

PDF of a PowerPoint presentation by Dr. Thomas Becker, Dr. Med. Consensus Development Conference on Improving Mental Health Transitions

PDF of a PowerPoint presentation by Dr. Thomas Raedler, MD. Consensus Development Conference on Improving Mental Health Transitions

PDF of a PowerPoint presentation by Mr. Howard Sapers. Consensus Development Conference on Improving Mental Health Transitions

PDF of a PowerPoint presentation by Dr. Tim Aubry, BA, MA, PhD. Consensus Development Conference on Improving Mental Health Transitions

PDF of a PowerPoint presentation by Ms. Sara Lapsley, BA, MA (Candidate). Consensus Development Conference on Improving Mental Health Transitions

PDF of a PowerPoint presentation by Dr. Scott Patten, MD, FRCPC, PhD. Consensus Development Conference on Improving Mental Health Transitions

PDF of a PowerPoint presentation by Dr. Oliver Mason, DPhil, DClinPsy. Consensus Development Conference on Improving Mental Health Transitions

PDF of a PowerPoint presentation by Dr. Roger Bland, CM, MB, ChB, FRCPC, FRCPsych. Consensus Development Conference on Improving Mental Health Transitions

2 November 2014 Toronto, Ontario In April 2014, we held the first roundtable discussion on the current and future role of real world evidence (RWE) in Canada, bringing together multiple stakeholders from across Canada and internationally. Workshop participants felt there was much more to explore in future discussion and a specific need was identified to focus part of future conversations…

Biographies Chris Henshall Health Economics Research Group (HERG), Brunel University Dr. Chris Henshall is an Honorary Professor at HERG and an independent consultant on health, research and innovation policy. Chris has held various academic and senior management positions in the health research system and the higher education system in the UK. He is an Associate Professor in the…

Sunday, 2 November 2014 Toronto, Ontario Opening and Opening Remarks John Sproule, IHE Lisa Marsden, VP of Market Access & Government Relations at AstraZeneca Canada Vasanthi Srinivasan, Executive Director, Ontario SPOR DSU PART I: Fit for purpose: When and where is real-world evidence most useful? Speaker: Muhammad Mamdani, Director, Applied Health Research Centre, St. Michael's…

Roundtable Final Report Roundtable on Real World Evidence: System Readiness – Are we ready to use routinely collected data to improve health system performance? Summary Report – September 2014Download Roundtable Final Report Program Real World Evidence: Priority Setting for Action – How to best use health system data to improve health?Download Program

Real World Evidence: Priority Setting for Action was an invitational roundtable discussion organized by the Institute of Health Economics (IHE) and supported by and developed in partnership with Strategy for Patient Oriented Research Support Unit (Ontario) and AstraZeneca Canada. It was held in conjunction with the annual Canadian Association for Population Therapeutics (CAPT).…

Real World Evidence: System Readiness – Are we ready to use routinely collected data to improve health system performance? Summary Report Real World Evidence: Priority Setting for Action was an invitational roundtable discussion organized by the Institute of Health Economics (IHE) and supported by and developed in partnership with Strategy for Patient Oriented Research Support…

PDF of a PowerPoint presentation by Dr. Muhammad Mamdani, Director, Applied Health Research Centre, St. Michael's Hospital. Real World Evidence: Priority Setting for Action Roundtable

PDF of a PowerPoint presentation by Mr. Neil Corner, Director, Innovative Solutions (Real World Evidence Lead) at IMS Brogan. Real World Evidence: Priority Setting for Action Roundtable

  Objectives: To estimate incidence and prevalence of FASD by sex and age in Alberta, Canada.

  Abstract: Canadian and US health systems have often been characterized as having vastly different approaches to the financing and delivery of healthcare, with Canada portrayed as more reliant on rationing based on costs. In this article, we examine the similarities and differences between the two countries, the evolution and current role of health economic evaluation, and…

Welcome to our sitemap. From here you can navigate through the first level of our site.

Published quarterly by the KRP Tax Group, our newsletter provides up-to-date information regarding the latest tax rules and accounting principles. To subscribe to our electronic newsletter, please fill out the form below:

Institute of Health Economics Privacy Policy Your privacy is very important to us. Accordingly, we have developed this Policy in order for you to understand how we collect, use, communicate and disclose and make use of personal information. The following outlines our privacy policy. Before or at the time of collecting personal information, we will identify the purposes for which…

Subscribe to IHE Mailing List To subscribe to an IHE mailing list, please click the Subscriptions link. To unsubscribe from our mailing list at any time, please contact us at info@ihe.ca. Subscribe to IHE Mailing List  General Inquiries The Institute of Health Economics welcomes your inquiries. If you wish to receive more information about any of our products or services,…

Alberta STE Report written under contract with the Alberta Health Technologies Decision Process (AHTDP). This report is an evidence assessment of the clinical effectiveness and safety of hysteroscopic tubal sterilization, and the value for money associated with adopting hysteroscopic tubal sterilization in Alberta. Section Authors: Section One – Background and Context: Carmen…

Alberta STE Report written under contract with the Alberta Health Technologies Decision Process (AHTDP). This report is an evidence assessment of the best available research evidence on the safety and effectiveness, cost effectiveness and budget impact of using Endovenous Laser Ablation (EVLA) or Endovenous Radiofrequency Ablation (RFA) in the management of symptomatic varicose…

  OBJECTIVE: To provide Canadian estimates of health care utilization costs associated withrheumatoid arthritis (RA)-related and non-RA-related care within 4 treatment strategies and in different physical functioning categories.

Alberta STE Report written under contract with the Alberta Health Technologies Decision Process (AHTDP). This report examines the safety, screening accuracy, therapeutic efficacy, patient outcomes and cost effectiveness of first trimester Quad (1T-Quad) +/- NT and NIPT screening for fetal trisomies. Section Authors: Section One – Technology Effectiveness and Safety: Ken Bond,…

  OBJECTIVE: Sustained remission in rheumatoid arthritis (RA) results in healthcare utilizationcost savings. We evaluated the variation in estimates of savings when different definitions ofremission [2011 American College of Rheumatology/European League Against Rheumatism Boolean Definition, Simplified Disease Activity Index (SDAI) ≤ 3.3, Clinical Disease Activity Index…

  BACKGROUND: Interest in the well-being of physicians has increased because of their contributions to the healthcare system quality. There is growing recognition that physicians are exposed to workplace factors that increase the risk of work stress. Long-term exposure to high work stress can result in burnout. Reports from around the world suggest that about one-third to…

Summary of Systematic Reviews, Primary Studies, and Evidence-based Guidelines. The following research questions were addressed in this review: What are the clinical effects of a universal screening strategy for ARO carriage when compared with no screening? What are the clinical effects of a universal screening strategy for ARO carriage when compared with targeted screening (screening…

This discussion paper has been produced in response to a request from CIHR Institute of Health Services and Policy Research (CIHR IHSPR). The discussion paper will provide guidance to those tasked with conducting an economic evaluation of complex health system interventions. The guidance will be an elaboration of existing National guidelines for economic evaluation, and serve as…

Antibiotic-Resistant Organisms (AROs) are a serious health problem, though they are more prevalent in some settings than others. We were asked to make findings and develop recommendations on how to address surveillance of and screening for AROs in acute care hospitals. This consensus statement addresses these requests. However, confining the discussion and recommendations to hospitals…

PDF of a PowerPoint presentation by Dr. Elizabeth Bryce, BSc, MD, FRCPC. Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)

PDF of a PowerPoint presentation by Dr. Daniel Gregson, MD, FRCPC. Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)

PDF of a PowerPoint presentation by Dr. Lindsay Nicolle, BSc, BSc (med), MD, FRCPC. Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)

PDF of a PowerPoint presentation by Dr. Anthony Harris, MD, MPH. Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)

PDF of a PowerPoint presentation by Dr. Barry Cookson, BDS, MBBS, MSc, HonDipHIC, FRSPH, FRCP, FFPH, FRCPath. Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)

PDF of a PowerPoint presentation by Ms. Kim Neudorf. Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)

PDF of a PowerPoint presentation by Dr. Yves Longtin, MD, FRCPC. Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)

PDF of a PowerPoint presentation by Dr. Trish Perl, MD, MSc. Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)

PDF of a PowerPoint presentation by Dr. Eli Perencevich, MD, MS. Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)

PDF of a PowerPoint presentation by Dr. Mark Loeb, BSc, MSc, MD, FRCPC. Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)

PDF of a PowerPoint presentation by Dr. Serge Desnoyers, PhD. Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)

18 – 20 June 2014 Calgary, Alberta The 3-day Canadian Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs) held in Calgary, Alberta from June 18 – 20, 2014, was the first event of its kind to look at issues in the field of AROs. Download Consensus Statement The Consensus Conference model is an exciting format,…

Speakers | Jury | Scientific Committee | Organizing Committee  Speakers Elizabeth Bryce, BSc, MD, FRCPCRegional Medical Director for Infection Control, Vancouver Coastal Health; Clinical Professor, University of British Columbia (UBC) Barry Cookson, BDS, MBBS, MSc, HonDipHIC, FRSPH, FRCP, FFPH, FRCPathProfessor, University College and London School…

Weds 18 June 2014 | Thurs 19 June 2014 | Fri 20 June 2014 Surveillance and Screening for Antimicrobial Resistant Organisms (AROs) 2014 - Final Program Wednesday, 18 June 2014 08:00 – 08:15 Opening RemarksDr. John Conly and Dr. James Talbothttp://vimeo.com/channels/910470/99417520  08:15 – 09:45 QUESTION 1: Overview a) What are AROs? What is their incidence…

Program Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs) 2014 – Final ProgramDownload Program Consensus Statement Consensus Statement on Surveillance and Screening of AROs (Antimicrobial-Resistant Organisms)Download Consensus Statement Remarks from Jury Chair Remarks from the jury chair, Dr. Tom Marrie, Dean of…

PDF of a PowerPoint presentation by Dr. Pilar Ramon-Pardo, MD, PhD. Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)

PDF of a PowerPoint presentation by Dr. Howard Njoo, MD, MHSc. Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)

PDF of a PowerPoint presentation by Dr. Julian Davies, BSc, PhD, FRS. Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)

PDF of a PowerPoint presentation by Dr. Scott McEwen, DVM, DVSc, Dip ACVP. Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)

PDF of a PowerPoint presentation by Dr. Joel Kettner, MD, MSc, FRCSC, FRCPC. Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)

PDF of a PowerPoint presentation by Dr. Andrew Simor, MD, FRCPC. Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)

PDF of a PowerPoint presentation by Dr. Robert Weinstein, MD. Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)

PDF of a PowerPoint presentation by Dr. James Talbot, PhD, MD, FRCPC. Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)

PDF of a PowerPoint presentation by Dr. David Patrick, MD, FRCPC, MHSc. Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)

PDF of a PowerPoint presentation by Dr. Michael Edmond, MD, MPH, MPA. Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)

PDF of a PowerPoint presentation by Dr. Henri Verbrugh, MD, PhD, FIDSA. Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)

PDF of a PowerPoint presentation by Dr. Allison McGeer, MD, FRCPC. Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)

PDF of a PowerPoint presentation by Dr. Susan Huang, MD, MPH. Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)

PDF of a PowerPoint presentation by Dr. John Jernigan, MD, MS. Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)

The 3-day Canadian Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs) held in Calgary, Alberta from June 18 - 20, 2014, was the first event of its kind to look at issues in the field of AROs.

Congratulations to Dr. Egon Jonsson, winner of the 2014 David Banta Award. Edmonton – Institute of Health Economics’ (IHE) Executive Director and CEO, Egon Jonsson, Ph.D., is the winner of the 2014 “H. David Banta Distinguished Career Award” in the field of health technology assessment (HTA). The award was announced at the meeting of Health Technology…

  BACKGROUND: Interest in the impact of burnout on physicians has been growing because of the possible burden this may have on health care systems. The objective of this study is toestimate the cost of burnout on early retirement and reduction in clinical hours of practicingphysicians in Canada.

The objective of this paper is to estimate the additional costs to the criminal justice system associated with people with mental illness who go through the system. The focus of the report is on costs in Alberta.

Alberta STE Report written under contract with the Alberta Health Technologies Decision Process (AHTDP). This report examines the potential role of low dose computed tomography (LDCT) in screening for lung cancer in adults aged 50 years or older in Alberta. Section Authors: Section One – Social and System Demographics Analysis: Bing Guo, Dagmara Chojecki Section Two –…

Thursday, 29 May 2014 Edmonton, Alberta The Future of Biologic and Biosimilar Therapies for the Management of Rheumatoid Arthritis in Alberta Health Care Key Symposium Documents Biologic and Biosimilar Therapies: The Future of Biologic and Biosimilar Therapies for the Management of Rheumatoid Arthritis in Alberta Health Care – Symposium ProgramDownload Program …

Speaker Biographies Dianne Mosher, MD Dr. Dianne Mosher is currently Professor of Medicine and the Chief of the Division of Rheumatology at the University of Calgary. She has practiced Rheumatology for the past twenty years having graduated from Dalhousie Medical School in 1983 where she also completed her Internal Medicine and Rheumatology residency training. Dr. Mosher is a past…

Thursday, 29 May 2014 Edmonton, Alberta Moderator Dianne Mosher, University of Calgary 09:00 – 09:15 Welcome and Opening Remarks Michele Evans, Executive Director, Pharmaceutical Funding and Guidance, Government of Albertahttp://vimeo.com/album/3477664/video/97379108 09:15 – 09:30 Biologic and Biosimilar Therapies - The Changing Landscape of the Management of Rheumatoid…

Symposium Program Biologic and Biosimilar Therapies: The Future of Biologic and Biosimilar Therapies for the Management of Rheumatoid Arthritis in Alberta Health Care – Symposium ProgramDownload Program  White Paper Rheumatoid Arthritis in a Policy Perspective: A registry for research and better treatment of Albertans – White PaperDownload White Paper

PDF of PowerPoint Presentation by Dr. Dianne Mosher, Chief, Division of Rheumatology, Department of Medicine, University of Calgary.  Biologic and Biosimilar Therapies: The Future of Biologic and Biosimilar Therapies for the Management of Rheumatoid Arthritis in Alberta Health Care Symposium

PDF of a PowerPoint Presentation by Dr. Liam Martin, Professor, University of Calgary. Biologic and Biosimilar Therapies: The Future of Biologic and Biosimilar Therapies for the Management of Rheumatoid Arthritis in Alberta Health Care Symposium

PDF of a PowerPoint Presentation by Ms. Cheryl Koehn, Founder and President, Arthritis Consumer Experts (ACE). Biologic and Biosimilar Therapies: The Future of Biologic and Biosimilar Therapies for the Management of Rheumatoid Arthritis in Alberta Health Care Symposium

PDF of a PowerPoint Presentation by Dr. Micheal Guirguis, Drug Stewardship Pharmacist, Alberta Health Services (AHS). Biologic and Biosimilar Therapies: The Future of Biologic and Biosimilar Therapies for the Management of Rheumatoid Arthritis in Alberta Health Care Symposium

PDF of a PowerPoint Presentation by Ms. Suzanne Lepage, Private Health Plan Strategist.  Biologic and Biosimilar Therapies: The Future of Biologic and Biosimilar Therapies for the Management of Rheumatoid Arthritis in Alberta Health Care Symposium

PDF of a PowerPoint Presentation by Dr. Agnes Klein, Director, Centre for Evaluation of Radiopharmaceuticals and Biotherapeutics at Health Canada, Health Canada. Biologic and Biosimilar Therapies: The Future of Biologic and Biosimilar Therapies for the Management of Rheumatoid Arthritis in Alberta Health Care Symposium Note: Slide 16 of this presentation contains an error…

PDF of a PowerPoint Presentation by Dr. Chander Sehgal, Director, Common Drug Review (CDR) and Optimal Use, Canadian Agency for Drugs and Technologies in Health (CADTH).  Biologic and Biosimilar Therapies: The Future of Biologic and Biosimilar Therapies for the Management of Rheumatoid Arthritis in Alberta Health Care Symposium

Biologic and Biosimilar Therapies: The Future of Biologic and Biosimilar Therapies for the Management of Rheumatoid Arthritis in Alberta Health Care.

Speaker Biographies Keynote Speakers Dr. Sube Banerjee MB BS, MSc, MBA, MD, FRC Psych, MBEProfessor & Associate Dean, Brighton and Sussex Medical School Sube Banerjee is Professor of Dementia and Associate Dean for Strategy at Brighton and Sussex Medical School, directing its Centre for Dementia Studies. Clinically he works as an old age psychiatrist in Sussex. He was the Department…

27 May 2014Edmonton, Alberta Welcome and Greetings from the Minister of Health Honourable Fred Horne, Minister of Healthhttp://vimeo.com/channels/907291/97426151  Keynote presentations Quality of life and quality of care in dementiaDr. Sube Banerjee, Brighton and Sussex Medical SchoolDownload Presentation http://vimeo.com/channels/907291/97466183  Coordinating Care…

27 May 2014 Edmonton, Alberta Meeting the Challenge: Dementia and Continuing Care is the 11th IHE Innovation Forum, a semi-annual event bringing together senior public- and private-sector experts and decision-makers to address health care policy issues. Key Forum Documents Innovation Forum XI – Meeting the Challenge: Dementia and Continuing Care – FINAL PROGRAMDownload…

Meeting the Challenge: Dementia and Continuing Care is the 11th IHE Innovation Forum, a semi-annual event bringing together senior public- and private-sector experts and decision-makers to address health care policy issues.

PDF of a PowerPoint presentation by Dr. Sube Banerjee, Brighton and Sussex Medical School. IHE Innovation Forum XI – Meeting the Challenge: Dementia and Continuing Care

PDF of a PowerPoint presentation by Dr. Duncan Robertson, Seniors Health Strategic Clinical Network, Alberta Health Services. IHE Innovation Forum XI – Meeting the Challenge: Dementia and Continuing Care

PDF of a PowerPoint presentation by Dr. Carole Estabrooks, University of Alberta. IHE Innovation Forum XI – Meeting the Challenge: Dementia and Continuing Care

PDF of a PowerPoint presentation by Mrs. Corinne Schalm, Alberta Health. IHE Innovation Forum XI – Meeting the Challenge: Dementia and Continuing Care

PDF of a PowerPoint presentation by Dr. David C. Grabowski, Harvard Medical School. IHE Innovation Forum XI – Meeting the Challenge: Dementia and Continuing Care

Meeting the Challenge: Dementia and Continuing Care is the 11th IHE Innovation Forum, a semi-annual event bringing together senior public- and private-sector experts and decision-makers to address health care policy issues.

This informative PowerPoint is publicly available for use as an introductory resource for justice professionals who are seeking an educational tool to assist in group presentations/training regarding involvement of those with Fetal Alcohol Spectrum Disorder (FASD) in the criminal justice system.

Le PowerPoint informative est publiquement disponible pour une utilisation en tant que ressource d'introduction pour les professionnels de la justice qui cherchent un outil pédagogique pour aider à des présentations de groupe / formation concernant la participation de ceux qui ont des troubles causés par l'alcoolisation fœtale (ETCAF ) dans le…

  Should vitamin B12 tablets be included in more Canadian drug formularies? An economic model of the cost-saving potential from increased utilisation of oral versus intramuscular vitamin B12 maintenance therapy for Alberta seniors. OBJECTIVE: The aim of this study was to estimate the cost-savings attainable if all patients aged ≥65 years in Alberta, Canada, currently on…

  OBJECTIVES: The objective of this study was to explore the degree to which databases otherthan MEDLINE contribute studies relevant for inclusion in rapid health technology assessments (HTA).

This report has been produced in response to a request from Alberta Health (AH). The objective was to perform a review of practices of engaging committees composed of lay people or members of the general public at international, national, provincial, and regional levels. The review attempts to address the following questions: What scientific evidence is available about committees…

  The International Charter on Prevention of FASD has been published in The Lancet Global Health, one of the world’s most influential public-health journals.  The Charter – also known as the “Edmonton Charter” – was endorsed at the First International Conference on Prevention of FASD in September 2013.The Edmonton Charter was drafted by senior…

The International Charter on Prevention of FASD has been published in The Lancet Global Health, one of the world’s most influential public-health journals. The Charter – also known as the “Edmonton Charter” – was endorsed at the First International Conference on Prevention of FASD in September 2013.The Edmonton Charter was drafted by senior staff of…

The International Charter on Prevention of FASD has been published in The Lancet Global Health, one of the world’s most influential public-health journals. The Charter – also known as the “Edmonton Charter” – was endorsed at the First International Conference on Prevention of FASD in September 2013.The Edmonton Charter was drafted by senior staff of…

The International Charter on Prevention of FASD has been published in The Lancet Global Health, one of the world’s most influential public-health journals. The Charter – also known as the “Edmonton Charter” – was endorsed at the First International Conference on Prevention of FASD in September 2013.The Edmonton Charter was drafted by senior staff of…

The International Charter on Prevention of FASD has been published in The Lancet Global Health, one of the world’s most influential public-health journals. The Charter – also known as the “Edmonton Charter” – was endorsed at the First International Conference on Prevention of FASD in September 2013.The Edmonton Charter was drafted by senior staff of…

The International Charter on Prevention of FASD has been published in The Lancet Global Health, one of the world’s most influential public-health journals. The Charter – also known as the “Edmonton Charter” – was endorsed at the First International Conference on Prevention of FASD in September 2013.The Edmonton Charter was drafted by senior staff of…

The International Charter on Prevention of FASD has been published in The Lancet Global Health, one of the world’s most influential public-health journals. The Charter – also known as the “Edmonton Charter” – was endorsed at the First International Conference on Prevention of FASD in September 2013.The Edmonton Charter was drafted by senior staff of…

  BACKGROUND: The use of a restrictive formulary, with placement determined through a drug-reimbursement decision-making process, is one approach to managing drug expenditures.

IHE In Your Pocket 2014 – a handbook of health economic statistics includes the most currently available data, presented in separate sections on the economic burden of illness, health care resources, health behaviours, health status and demographics, and health system performance. IHE In Your Pocket was designed to provide a compact, comprehensive, and comparative overview…